R&D Systems Inc. Tocris Bioscience Boston Biochem

Miscellaneous Glutamate

Inhibitors
Cat.No.
Product Name / Activity
1380 PMPA (NAALADase inhibitor)
Highly potent, selective NAALADase (GCP II) inhibitor
0768 Riluzole hydrochloride
Glutamate release inhibitor/GABA uptake inhibitor
2675 ZJ 43
Glutamate carboxypeptidase II and III (NAALADase, NAAG peptidase) inhibitor
Other
Cat.No.
Product Name / Activity
3618 Acamprosate calcium
Glutamatergic modulator and GABA agonist
0395 N-Acetylglycyl-D-glutamic acid
Potent convulsant
0341 L-AP6
Selective agonist of the 'quis' effect
2538 L-BMAA hydrochloride
Neurotoxic amino acid
0262 2,4-Dihydroxyphenylacetyl-L-asparagine
Component of Joro spider toxin
1611 Lamotrigine
Inhibits glutamate release. Anticonvulsant
2289 Lamotrigine isethionate
Inhibits glutamate release. Water-soluble salt of lamotrigine (Cat. No. 1611)
3272 (±)-LY 395756
Mixed mGlu2 agonist/ mGlu3 antagonist
1490 MNI-caged-L-glutamate
Stable photoreleaser of L-glutamate
2687 Pentylenetetrazole
CNS stimulant
3574 RuBi-Glutamate
Caged glutamate; excited by visible wavelengths
0636 Salsolinol-1-carboxylic acid
Endogenous amino acid
0391 Spaglumic acid
Putative endogenous neurotransmitter
3847 Theanine
Glutamate receptor ligand
2625 Zonisamide
Anticonvulsant, modulates glutamate neurotransmission

Quick Order

Find multiple products by catalog number

divider line

Pain Research Guide

Reserve your free copy

Pain Research Guide

Highlights over 280 products for Pain research. Reserve copy

divider line

mGlu Receptors Review

Metabotropic Glutamate Receptors Review

Written by Francine Acher, an expert in the field. Request a copy or view PDF today.

divider line

Neurobiology of Parkinson's Disease

Written by A. Schapira

Parkinson's Poster

'Neurobiology and Therapeutics of Parkinson's Disease' highlights the neurobiology of Parkinson's disease and summarizes current and novel therapeutic interventions.

divider line

7-TM Receptor Signaling

Written by T. Kenakin et al

7-TM Poster

'Seven Transmembrane Receptor Signaling' highlights the multiple behaviors of 7-TMs including G-protein-dependent and -independent signaling as well as the concept of collateral efficacy

divider line

Antidepressants - Current and Future Targets

Written by P. Skolnich et al

Antidepressants poster

'Antidepressants - Current and Future Targets' provides an overview of the current and future targets for the treatment of major depressive disorder.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions